Disparities, Controversies, and Emerging Directions
Equity, Benzodiazepine Controversy, Psychedelics, Digital Tools & Prevention
Lessons
7 in this chapter7.1
The Treatment Gap: Who Gets Missed and Why
7.2
The Benzodiazepine Debate: History and the Attribution Problem
7.3
The Benzodiazepine Debate: Guidelines, Deprescribing, and Your Practice
7.4
Emerging Pharmacotherapy
7.5
Digital Therapeutics
7.6
Prevention and the Overtreatment/Undertreatment Paradox
7.7
Clinical Vignettes, Key Takeaways, and Key References